DrugPatentWatch Database Preview
Hikma Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for HIKMA, and when can generic versions of HIKMA drugs launch?
HIKMA has three hundred and thirty approved drugs.
There are five US patents protecting HIKMA drugs. There are two tentative approvals on HIKMA drugs.
Summary for Hikma
| US Patents: | 5 |
| Tradenames: | 229 |
| Ingredients: | 212 |
| NDAs: | 330 |
| Patent Litigation for Hikma: | See patent lawsuits for Hikma |
| PTAB Cases with Hikma as petitioner: | See PTAB cases with Hikma as petitioner |
Drugs and US Patents for Hikma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | SOLUTION;ORAL | 203208-001 | Jul 12, 2013 | AA | RX | No | No | Start Trial | Start Trial | ||||
| Hikma | GRANISETRON HYDROCHLORIDE | granisetron hydrochloride | TABLET;ORAL | 077842-001 | Dec 31, 2007 | AB | RX | No | Yes | Start Trial | Start Trial | ||||
| Hikma Pharms | MODAFINIL | modafinil | TABLET;ORAL | 090543-001 | Sep 26, 2012 | DISCN | No | No | Start Trial | Start Trial | |||||
| Hikma Intl Pharms | HYDROCORTISONE | hydrocortisone | TABLET;ORAL | 083365-003 | Feb 23, 2015 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hikma Pharms | GLIMEPIRIDE | glimepiride | TABLET;ORAL | 078952-001 | Aug 1, 2013 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Hikma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Hikma | ATIVAN | lorazepam | INJECTABLE;INJECTION | 018140-001 | Approved Prior to Jan 1, 1982 | 4,017,616 | Start Trial |
| Hikma | ATIVAN | lorazepam | INJECTABLE;INJECTION | 018140-002 | Approved Prior to Jan 1, 1982 | 4,017,616 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for HIKMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Capsules | 0.6 mg | ➤ Subscribe | 2016-06-10 |
| ➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
| ➤ Subscribe | Tablets | 1 mg | ➤ Subscribe | 2009-08-14 |
| ➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
